囊泡运输是急性髓系白血病他汀反应的关键决定因素
本研究通过化学筛选原代人急性髓系白血病(AML)标本,发现亲脂性他汀可强效抑制多种细胞遗传学亚型AML;遗传筛选揭示蛋白香叶基香叶基化及RAB蛋白介导的囊泡运输在他汀影响AML细胞活力中起关键作用,他汀可抑制原代标本的囊泡运输,敏感样本表达谱提示囊泡运输增强。
要点
- 亲脂性他汀可强效抑制多种细胞遗传学亚型的原代人AML标本。
- 蛋白香叶基香叶基化及RAB蛋白协调的囊泡运输介导他汀对AML细胞活力的影响。
- 他汀敏感样本表达签名提示囊泡运输增强。
核心结论
- 本研究揭示了他汀在AML中的作用机制,并识别出细胞遗传学多样性AML的一个新脆弱点。
研究设计与样本
- 研究对原代人AML标本进行化学筛选和遗传筛选,以识别他汀反应的调节因子。
主要发现
- 化学筛选将亲脂性他汀鉴定为来自广泛细胞遗传学组的AML的强效抑制剂。
- 遗传筛选揭示蛋白香叶基香叶基化及协调囊泡运输多个方面的RAB蛋白在他汀介导的AML细胞活力效应中起作用。
- 他汀可抑制原代人标本中的囊泡介导运输,他汀敏感样本显示提示囊泡运输增强的表达签名。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cholesterol homeostasis has been proposed as one mechanism contributing to chemoresistance in AML and hence, inclusion of statins in therapeutic regimens as part of clinical trials in AML has shown encouraging results. Chemical screening of primary human AML specimens by our group led to the identification of lipophilic statins as potent inhibitors of AMLs from a wide range of cytogenetic groups. Genetic screening to identify modulators of the statin response uncovered the role of protein geranylgeranylation and of RAB proteins, coordinating various aspect of vesicular trafficking, in mediating the effects of statins on AML cell viability. We further show that statins can inhibit vesicle-mediated transport in primary human specimens, and that statins sensitive samples show expression signatures reminiscent of enhanced vesicular trafficking. Overall, this study sheds light into the mechanism of action of statins in AML and identifies a novel vulnerability for cytogenetically diverse AML.
引用
- Krosl J, Bordeleau ME, Moison C, et al. Vesicular trafficking is a key determinant of the statin response in acute myeloid leukemia. Blood Adv. 2022. PMID: 34731885. doi:10.1182/bloodadvances.2021006047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。